Adult-onset dystonia-parkinsonism

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:199351OMIM:612953G24.1
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Adult-onset dystonia-parkinsonism (Orphanet code 199351) is a rare neurological disorder characterized by the combined presence of dystonia and parkinsonian features that manifest in adulthood. Dystonia refers to sustained or intermittent involuntary muscle contractions causing abnormal, often repetitive movements and postures, while parkinsonism encompasses symptoms such as bradykinesia (slowness of movement), rigidity, resting tremor, and postural instability. The condition primarily affects the central nervous system, particularly the basal ganglia circuits that control voluntary movement. Patients typically present in adulthood with progressive motor difficulties. Dystonia may affect the limbs, trunk, neck (cervical dystonia), or face, and parkinsonian features may develop concurrently or sequentially. The combination of these two movement disorder phenotypes can significantly impair daily functioning, mobility, and quality of life. The clinical presentation can vary considerably between individuals, and the condition may overlap with or be difficult to distinguish from other forms of dystonia-parkinsonism syndromes that have specific genetic etiologies. Treatment is primarily symptomatic and supportive. Levodopa therapy may be trialed, though the response can be variable and is often less robust than in idiopathic Parkinson's disease. Other medications used include anticholinergics, dopamine agonists, and muscle relaxants. Botulinum toxin injections may be helpful for focal dystonia. Deep brain stimulation (DBS) has been considered in refractory cases. Physical therapy, occupational therapy, and speech therapy play important roles in maintaining function and managing disability. There is currently no curative treatment available.

Also known as:

Clinical phenotype terms— hover any for plain English:

Hypometric saccadesHP:0000571Eyelid apraxiaHP:0000658Frontotemporal dementiaHP:0002145Neurofibrillary tanglesHP:0002185Parkinsonism with favorable response to dopaminergic medicationHP:0002548Focal dystoniaHP:0004373Frontotemporal cerebral atrophyHP:0006892Generalized cerebral atrophy/hypoplasiaHP:0007058Progressive extrapyramidal movement disorderHP:0007153DyslexiaHP:0010522
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Adult-onset dystonia-parkinsonism.

View clinical trials →

No actively recruiting trials found for Adult-onset dystonia-parkinsonism at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Adult-onset dystonia-parkinsonism community →

Specialists

1 foundView all specialists →
HM
Harrison C Walker, MD
BIRMINGHAM, AL
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Adult-onset dystonia-parkinsonism.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Adult-onset dystonia-parkinsonismForum →

No community posts yet. Be the first to share your experience with Adult-onset dystonia-parkinsonism.

Start the conversation →

Latest news about Adult-onset dystonia-parkinsonism

No recent news articles for Adult-onset dystonia-parkinsonism.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Adult-onset dystonia-parkinsonism

What is Adult-onset dystonia-parkinsonism?

Adult-onset dystonia-parkinsonism (Orphanet code 199351) is a rare neurological disorder characterized by the combined presence of dystonia and parkinsonian features that manifest in adulthood. Dystonia refers to sustained or intermittent involuntary muscle contractions causing abnormal, often repetitive movements and postures, while parkinsonism encompasses symptoms such as bradykinesia (slowness of movement), rigidity, resting tremor, and postural instability. The condition primarily affects the central nervous system, particularly the basal ganglia circuits that control voluntary movement.

At what age does Adult-onset dystonia-parkinsonism typically begin?

Typical onset of Adult-onset dystonia-parkinsonism is adult. Age of onset can vary across affected individuals.

Which specialists treat Adult-onset dystonia-parkinsonism?

1 specialists and care centers treating Adult-onset dystonia-parkinsonism are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.